Anti-Ageing Conference London – Speaker Spotlight

London: The latest advances in preventative dental health and chelation are the subject of of speaker Brian Halvorsen’s presentation to the Anti-Ageing Conference London 2006.

Mr Halvorsen BDS LDS, RCS. FRSH founded the Prestwood Dental Health Centre. Founder Member British Nutrition Society. Founder Member IAOMT (International Academy of Oral Medicine & Toxicology). Founder Member Mercury Free Society. Founder of CDP Dental TV. Section chairman BDA.

When his practice was first founded in 1977 Brian pioneered the principles of prevention, with an emphasis on dental hygiene and education and has always employed professional advisors in this areas.

In the early 80’s Brian’s concern turned to holistic dentistry and the effects of materials that were currently being used and became amalgam free in 1985. With the advancement of cosmetic dentistry as well as adhesive dentistry Brian saw the opportunity to combine non-toxic materials with less tooth destruction (non-reduction veneers) etc.

In 1986 Brian wrote and published ‘The Natural Dentist’ A Holistic Approach to Dental Disease ISBN 0-09-946720-8
Brian keeps pace with the latest dental practices through his involvement in courses and conferences on cosmetic dentistry and has acted as editor on programs for Dental TV which involved most of the worlds leading Cosmetic Dentists.

Brian lectures nationally on the subject of holistic dentistry and the safety precautions that can be taken to protect the dentist, staff and of course the patients.

Brian’s patients are often referred by doctors, naturopaths, homeopaths, nutritionists and other dentists to help diagnose potential toxicity problems. He also enjoys cosmetic dentistry including whitening as this a major part of holistic dentistry by making patient’s feel better about themselves and the huge boost in their self esteem.
This year Anti-Ageing Conference London has the largest gathering of the world’s pre-eminent medical speakers on the subject of anti-ageing health and regenerative medicine ever to be assembled in London.

The 3rd Anti-Ageing Conference (AACL), will be held at the Royal Society of Medicine in London from the 15-17 September 2006. This event offers a unique opportunity to learn from scientists and physicians about the latest medical advances from what some may consider controversial, to the proven and new treatments for the diseases of ageing.

This event is of importance to all medical professionals who wish to be cognisant on the latest medical and scientific developments in anti-ageing and rejuvenatory medicine from around globe. It is of particular importance to scientists, nutritionists, gerontologists, chiropractors, pharmacists, pharmaceutical chemists and research specialists, nursing practitioners, naturopathic doctors, dentists, bariatricians and weight management specialists.

Among the speakers are world-renowned experts who have driven the global debate on anti-ageing medicine including Dr Robert Goldman, Chairman, American Academy of Anti-Aging Medicine and Dr Ronald Klatz, Founding President, American Academy of Anti-Aging Medicine; Professor Imre Zs-Nagy, Professor John Ionescu, Dr Michael Klentze. Our keynote speaker on Sunday is Dr. Deepak Chopra, one of the world’s leaders in the field of mind body medicine and Auvyredic medicine.

As well as the opportunity to hear from these world experts and put questions to our speaker panel, this event provides a unique networking opportunity for healthcare professionals. All delegates receive a high-quality bound conference manual including speaker presentations and biographical materials. The fee also includes a buffet lunch, on all three days, refreshments and an invitation to the conference cocktail reception. In addition the latest anti-ageing products from around the world will be on show in the exhibition hall.

This prestigious scientific event will be introduced by Heather Bird-Tchenguiz MBA, Chairperson, AACL; Founder and President of HB Health; Director of the World Academy of Anti-Aging Medicine; Board Member, European Society of Anti-Aging Medicine and Director, British Society of Anti-Ageing Medicine.

Heather Bird-Tchenguiz comments: “In most societies around the globe people are living longer so the importance of healthy ageing has never been greater. It is possible for older people to live full and healthy lives well into the latter part of their years but in most cases this does not happen because they and the medical professional are not always aware of the new opportunities that are available to them through anti-ageing medicine. That is what this conference is all about and why this knowledge is so vital.”

The speaker programme for Anti-Ageing London 2006 is as follows:
Friday, 15 September – Regenerative and Preventative Medicine
Prof Larry Benowitz – (TBA)
Prof Geoffrey Raisman: Spinal cord injury
Prof David Naor PhD: Involvement of CD 44 in stem cell differentiation
Prof Stephen Minger – (TBA)
Prof Stefan Krauss PhD: Neural Cell Damage
Dr Dasa Ciscova PhD: The efficacy of stem cell therapy in animal models of autoimmune diseases
Prof Tomas Ekstrom: Karolinska Institutet Sweden: Epigentics principles
Dr Tony Pellet: Umbilical Cord stem cells
Dr Miomir Knecevic – (TBA)
Dr Ralf Tonjes PhD: Paul-Ehrlich –Institut: Stem Cell signatures as a tool for quality control of
Innovative medicinal products
Andreas Junge MBA: Knowledge Management
Dr Octavi Quintana Trias: EU politics
Dr Marco Traub: Symposium Overview
Saturday, 16 September
Professor Dr Imre Zs-Nazy: The Theories of Ageing
Dr Ben Pfeifer MD Ph.D: Prostate Cancer – Unique Protocols featuring Photonutrients and the Immounomodulator
Dr Mark Babizayev: Human Cataracts – the role of Lipid Peroxidation and the efficacy of N-acetylcarnosine as a treatment
Phil Micans PharmB: Biological Age Measurement – Practicalities and Issues
Dr Jennifer Krup MD ABAAM:HRT in Women : Questions. answers and more questions
Dr Brian Halvosen BDS LDS RCS FRSH: Dentistry – Advances with an emphasis on chelation and preventative health care
Dr Robert Goldman MD PhD FAASP DO FAOASM:
Prof Alfred Wolf: Chronic stress,burn-out and CFS, A new insight and preventive options
Patrick Holford BSc DipION FBant- Nutrition and Ageing
Sunday, 17 September
Dr Deepak Chopra
Dr Julian Kenyon: Photodynamic and Sonodynamic Therapy
Professor John Ionescu PhD: New Strategies to slow skin photoageing
Sarah Noble: Advances in Spa Medicine
Dr Eric Braverman, MD: Subclinical Hyperparathyroidism: A precursor of Osteoporosis and Dementia?
Dr Michael Klentze MD PhD ABAAM: Male Hormone Replacement
Dr Paul Clayton: Alzheimer’s Disease: Pharmaco-nutritional strategies to maintain the ageing brain
Dr Ron Klatz MD: Closing remarks including ‘New horizons for the clinical specialty of Anti-Aging Medicine: The Future with Biomedical Technologies.
The programme may be subject to change
Full details of the speaker programme and speaker biographies can be viewed at
There are various categories of registration for this event:
Full registration £350;
Day 1 Only £200;
Day 2 only £200;
Day 3 £200.
Book on-line on the registration page at www.antiageingconference.comMembership of certain medical societies may qualify for a discount. Further information may also be requested from
Telephone: +44 (0) 2075816962
The events sponsors and supporters include HB Health, the British Society of Anti-Ageing Medicine; the European Society of Anti-Aging Medicine; the World Academy of Anti-Aging Medicine and The Trans European Stem Cell Therapy Consortium.

Anti Ageing Conference London
PO Box 50622
London SW6 2YP
United Kingdom
Tel : +44 (0) 20 7581 6962
Fax : +44 (0) 20 7589 1273



Anita Baxas, M.D.
Sam Baxas, M.D.
Baxamed Switzerland
Hauptstrasse 4
CH-4102 Binningen
T: 4161-422-1295
T: 4161-422-1292
F: 4161-421-5665
F: 4161-422-1289
305-361-9249 US


Reza Tavassoli, MD, PhD
Biotonus Clinique Bon Port
21, rue Bon-Port
1820 Montreux
T: 41-21-966-57-57
F: 41-21-966-57-58 fax
email: or

LaClinic (anti-ageing and cosmetics)
Avenue de Collonge 43
1820 Montreaux-Territet
T: 41 21 966 70 00
F: 41 21 966 70 10


Walter Blumer, MD
8754 Netstal
Glarus Bei Zurich
Netstal Glarus
T: 41 58-61-28-46

Klinik Professor Sailer (aesthetic surgery)
Toblerstresse 51
CH-8044 Zurich
T: 41 44 2519152
F: 41 44 2519153


Chelation (pronounced key-lay-shun) is a chemical reaction that results in a bond being formed between a metal ion and an organic (i.e., carbon-based — made mostly of carbon) molecule. The resulting complex, metal bound to molecule, is called a “chelate” and contains one or more rings of atoms in which the metal ion is so firmly bound it cannot escape. This allows the metal ion to be transported in the same manner as a prisoner, first handcuffed, then moved from one location to another.

In the presence of aging and disease, the cells’ ability to move metal ions through the system and eliminate them when they are in excess becomes progressively impaired. This is especially true for calcium.

Calcium has vital functions in the human body. Without calcium, teeth and bones could not exist. Nevertheless, as the body ages, lipid peroxidation damages the walls of the arterial tree which is repaired leaving a scar. Then calcium and oxidized cholesterol are incorporated into the resulting scar tissue.

“Hardening of the arteries,” or arteriosclerosis, on the other hand, is apparently an inevitable change of aging. The walls of blood vessels become stiffer as time passes, as does all connective tissue of the body. This is caused by cross-linkage of collagen, the protein which makes up the connective tissue of artery walls. This cross-linkage results in loss of elasticity and flexibility. We believe the process can be slowed, but not entirely prevented, by the liberal intake of antioxidants, especially vitamin C.

With atherosclerosis, as the years pass, calcium deposits b uild up, and calcified atherosclerotic plaques form, lining the walls of the arterial vessels. This plaque is composed of various lipids, so-called foam cells, scar tissue, and overgrown smooth muscles cells from the artery wall. In many people, this process begins in early childhood.

With arteriosclerosis, calcium also builds up and becomes many times more concentrated in the wall of the normal artery than it was in childhood. Calcium content is what atherosclerosis and arteriosclerosis have in common. Aging can be thought of as a progressive dysfunction of calcium metabolism.

In distinction to the oral agents that serve to prevent atherosclerosis, intravenous chelation has been shown to actually reverse the effects of the disease. The agent used is ethylene-diamine-tetra-acetic acid, also known as “EDTA,” sold commercially as Sodium Edetate.

EDTA is a synthetic amino acid. The usual dose is 2000-3000 mg (adjusted to body weight, age, and kidney function) added to 500 ml of “carrier solution” — sterile water with a mixture of vitamins and minerals. Most chelation doctors add vitamin C along with B vitamins, bicarbonate and magnesium.

The solution is infused slowly, one drop per second, and one treatment requires about three hours. The prisoner (calcium) is moved out of the body using handcuffs (EDTA). The half life of EDTA in the body is one hour; i.e., one-half is removed (filtered into the urine) after one hour, another half of what is left is removed after one more hour, etc. Within 24 hours 99% of the EDTA is gone from the body, and you are left with only the therapeutic benefit.

1.EDTA lowers blood calcium and thus stimulates the production of parathormone from the parathyroid glands. This mild pulse of parathormone is responsible for the removal of calcium from abnormal locations (such as arteries) and the deposition of calcium in locations (such as bones) where it should be. This accounts for the mild recalcification of osteoporotic bones seen with EDTA.

2.EDTA stimulates the enlargement of small vessels, so that they serve the purpose of collateral circulation around a blockage, rendering the blockage irrelevant.

3.EDTA controls free radical damage due to lipid peroxidation by serving as a powerful antioxidant.

4.EDTA removes abnormally located metal ions, such as copper and iron, that accumulate with age.

5.EDTA removes lead, cadmium, aluminum, and other metals, restoring enzyme systems to their proper functions.

6.EDTA enhances the integrity of cellular and mitochondrial membranes.

7.EDTA helps reestablish prostaglandin hormone balance.Prostaglandins, among other things, are responsible for the balancing act between contraction and relaxation of arterial walls and between clotting and the free flow of blood. Prostaglandins are produced from fatty acids, therefore lipid peroxidation upsets the balance of these vital hormones. EDTA chelates out the catalyzing metallic co-enzymes and thus inhibits lipid peroxidation, also serving the same function as an antioxidant.

8.EDTA reduces the tendency of platelets to cause coagulation too readily. This tends to prevent inappropriate thrombosis, which blocks coronary arteries during a heart attack.

9.EDTA increases tissue flexibility by uncoupling age-related cross-linkages that are responsible for loss of skin tone and for wrinkling.